Gene expression in major depressive disorder
Tóm tắt
Từ khóa
Tài liệu tham khảo
Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014; 511: 421–427.
Gaugler T, Klei L, Sanders SJ, Bodea CA, Goldberg AP, Lee AB et al. Most genetic risk for autism resides with common variation. Nat Genet 2014; 46: 881–885.
Nurnberger JI Jr, Koller DL, Jung J, Edenberg HJ, Foroud T, Guella I et al. Identification of pathways for bipolar disorder: a meta-analysis. JAMA Psychiatry 2014; 71: 657–664.
Sullivan PF, Neale MC, Kendler KS . Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 2000; 157: 1552–1562.
Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium, Ripke S, Wray NR, Lewis CM, Hamilton SP, Weissman MM et al. A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry 2013; 18: 497–511.
Levinson DF, Mostafavi S, Milaneschi Y, Rivera M, Ripke S, Wray NR et al. Genetic studies of major depressive disorder: why are there no GWAS findings, and what can we do about it. in press.
Westra H-J, Peters MJ, Esko T, Yaghootkar H, Schurmann C, Kettunen J et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat Genet 2013; 45: 1238–1243.
Wright FA, Sullivan PF, Brooks AI, Zou F, Sun W, Xia K et al. Heritability and genomics of gene expression in peripheral blood. Nat Genet 2014; 46: 430–437.
Jansen R, Batista S, Brooks AI, Tischfield JA, Willemsen G, van Grootheest G et al. Sex differences in the human peripheral blood transcriptome. BMC Genomics 2014; 15: 33.
Charlesworth JC, Curran JE, Johnson MP, Göring HH, Dyer TD, Diego VP et al. Transcriptomic epidemiology of smoking: the effect of smoking on gene expression in lymphocytes. BMC Med Genomics 2010; 3: 29.
Fredrickson BL, Grewen KM, Coffey KA, Algoe SB, Firestine AM, Arevalo JMG et al. A functional genomic perspective on human well-being. Proc Natl Acad Sci USA 2013; 110: 13684–13689.
Van den Akker EB, Passtoors WM, Jansen R, van Zwet EW, Goeman JJ, Hulsman M et al. Meta-analysis on blood transcriptomic studies identifies consistently coexpressed protein-protein interaction modules as robust markers of human aging. Aging Cell 2014; 13: 216–225.
Sullivan PF, Fan C, Perou CM . Evaluating the comparability of gene expression in blood and brain. Am J Med Genet Neuropsychiatr Genet 2006; 141B: 261–268.
Davies MN, Lawn S, Whatley S, Fernandes C, Williams RW, Schalkwyk LC . To what extent is blood a reasonable surrogate for brain in gene expression studies: estimation from mouse hippocampus and spleen. Front Neurosci 2009; 3: 54.
Cai C, Langfelder P, Fuller TF, Oldham MCLuo R, van den Berg LH et al. Is human blood a good surrogate for brain tissue in transcriptional studies? BMC Genomics 2010; 11: 589.
Penninx BWJH, Milaneschi Y, Lamers F, Vogelzangs N . Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile. BMC Med 2013; 11: 129.
Zunszain PA, Hepgul N, Pariante CM . Inflammation and depression. Curr Top Behav Neurosci 2013; 14: 135–151.
Blume J, Douglas SD, Evans DL . Immune suppression and immune activation in depression. Brain Behav Immun 2011; 25: 221–229.
Vogelzangs N, Beekman ATF, van Reedt Dortland AKB, Schoevers RA, Giltay EJ, de Jonge P et al. Inflammatory and metabolic dysregulation and the 2-year course of depressive disorders in antidepressant users. Neuropsychopharmacology 2014; 39: 1624–1634.
Hepgul N, Cattaneo A, Zunszain PA, Pariante CM . Depression pathogenesis and treatment: what can we learn from blood mRNA expression? BMC Med 2013; 11: 28.
Mostafavi S, Battle A, Zhu X, Potash JB, Weissman MM, Shi J et al. Type I interferon signaling genes in recurrent major depression: increased expression detected by whole-blood RNA sequencing. Mol Psychiatry 2014; 19: 1267–1274.
Penninx BWJH, Beekman ATF, Smit JH, Zitman FG, Nolen WA, Spinhoven P et al. The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods. Int J Methods Psychiatr Res 2008; 17: 121–140.
Boomsma DI, Willemsen G, Sullivan PF, Heutink P, Meijer P, Sondervan D et al. Genome-wide association of major depression: description of samples for the GAIN Major Depressive Disorder Study: NTR and NESDA biobank projects. Eur J Hum Genet EJHG 2008; 16: 335–342.
Sullivan PF, de Geus EJC, Willemsen G, James MR, Smit JH, Zandbelt T et al. Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo. Mol Psychiatry 2009; 14: 359–375.
American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association: Washington, DC, USA, 1994.
Wittchen HU . Reliability and validity studies of the WHO–Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res 1994; 28: 57–84.
Shabalin AA . Matrix eQTL: ultra fast eQTL analysis via large matrix operations. Bioinforma Oxf Engl 2012; 28: 1353–1358.
Liu JZ, Mcrae AF, Nyholt DR, Medland SE, Wray NR, Brown KM et al. A versatile gene-based test for genome-wide association studies. Am J Hum Genet 2010; 87: 139–145.
Lips ES, Cornelisse LN, Toonen RF, Min JL, Hultman CM et alInternational Schizophrenia Consortium. Functional gene group analysis identifies synaptic gene groups as risk factor for schizophrenia. Mol Psychiatry 2012; 17: 996–1006.
Barry WT, Nobel AB, Wright FA . Significance analysis of functional categories in gene expression studies: a structured permutation approach. Bioinforma Oxf Engl 2005; 21: 1943–1949.
Langfelder P, Horvath S . WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 2008; 9: 559.
Wium-Andersen MK, Ørsted DD, Nielsen SF, Nordestgaard BG . Elevated C-reactive protein levels, psychological distress, and depression in 73, 131 individuals. JAMA Psychiatry 2013; 70: 176–184.
Glahn DC, Curran JE, Winkler AM, Carless MA, Kent JW, Charlesworth JC et al. High dimensional endophenotype ranking in the search for major depression risk genes. Biol Psychiatry 2012; 71: 6–14.
Shelton RC, Claiborne J, Sidoryk-Wegrzynowicz M, Reddy R, Aschner M, Lewis DA et al. Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol Psychiatry 2011; 16: 751–762.
Garbett KA, Vereczkei A, Kálmán S, Brown JA, Taylor WD, Faludi G et al. Coordinated messenger RNA/microRNA changes in fibroblasts of patients with major depression. Biol Psychiatry 2015; 77: 256–265.
Eyre H, Baune BT . Neuroplastic changes in depression: a role for the immune system. Psychoneuroendocrinology 2012; 37: 1397–1416.
Jones KA, Thomsen C . The role of the innate immune system in psychiatric disorders. Mol Cell Neurosci 2013; 53: 52–62.
Herbert TB, Cohen S . Depression and immunity: a meta-analytic review. Psychol Bull 1993; 113: 472–486.
Zorrilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax A et al. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 2001; 15: 199–226.
Howren MB, Lamkin DM, Suls J . Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009; 71: 171–186.
Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010; 67: 446–457.
Valkanova V, Ebmeier KP, Allan CL . CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J Affect Disord 2013; 150: 736–744.
Tsao C-W, Lin Y-S, Chen C-C, Bai C-H, Wu S-R . Cytokines and serotonin transporter in patients with major depression. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30: 899–905.
Cattaneo A, Gennarelli M, Uher R, Breen G, Farmer A, Aitchison KJ et al. Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline ‘predictors’ and longitudinal ‘targets’. Neuropsychopharmacology 2013; 38: 377–385.
Betten A, Dahlgren C, Hermodsson S, Hellstrand K . Serotonin protects NK cells against oxidatively induced functional inhibition and apoptosis. J Leukoc Biol 2001; 70: 65–72.
Hernandez ME, Martinez-Fong D, Perez-Tapia M, Estrada-Garcia I, Estrada-Parra S, Pavón L . Evaluation of the effect of selective serotonin-reuptake inhibitors on lymphocyte subsets in patients with a major depressive disorder. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol 2010; 20: 88–95.
Evans DL, Folds JD, Petitto JM, Golden RN, Pedersen CA, Corrigan M et al. Circulating natural killer cell phenotypes in men and women with major depression. Relation to cytotoxic activity and severity of depression. Arch Gen Psychiatry 1992; 49: 388–395.
Frank MG, Hendricks SE, Johnson DR, Wieseler JL, Burke WJ . Antidepressants augment natural killer cell activity: in vivo and in vitro. Neuropsychobiology 1999; 39: 18–24.
Cruess DG, Douglas SD, Petitto JM, Have TT, Gettes D, Dubé B et al. Association of resolution of major depression with increased natural killer cell activity among HIV-seropositive women. Am J Psychiatry 2005; 162: 2125–2130.
Hussaini SMQ, Choi C-I, Cho CH, Kim HJ, Jun H, Jang M-H . Wnt signaling in neuropsychiatric disorders: ties with adult hippocampal neurogenesis and behavior. Neurosci Biobehav Rev 2014; 47: 369–38310.1016/j.neubiorev.2014.09.005.
Sani G, Napoletano F, Forte AM, Kotzalidis GD, Panaccione I, Porfiri GM et al. The wnt pathway in mood disorders. Curr Neuropharmacol 2012; 10: 239–253.
Pilar-Cuéllar F, Vidal R, Díaz A, Castro E, dos Anjos S, Pascual-Brazo J et al. Neural plasticity and proliferation in the generation of antidepressant effects: hippocampal implication. Neural Plast 2013; 2013: 537265.
Wilkinson MB, Dias C, Magida J, Mazei-Robison M, Lobo M, Kennedy P et al. A novel role of the WNT-dishevelled-GSK3β signaling cascade in the mouse nucleus accumbens in a social defeat model of depression. J Neurosci 2011; 31: 9084–9092.
Pirooznia M, Seifuddin F, Judy J, Goes FS, Potash JB, Zandi PP . Metamoodics: meta-analysis and bioinformatics resource for mood disorders. Mol Psychiatry 2014; 19: 748–749.
Cole SW, Hawkley LC, Arevalo JM, Sung CY, Rose RM, Cacioppo JT . Social regulation of gene expression in human leukocytes. Genome Biol 2007; 8: R189.
Ramasamy A, Trabzuni D, Guelfi S, Varghese V, Smith C, Walker R et al. Genetic variability in the regulation of gene expression in ten regions of the human brain. Nat Neurosci 2014; 17: 1418–1428.
Nieratschker V, Massart R, Gilles M, Luoni A, Suderman MJ, Krumm B et al. MORC1 exhibits cross-species differential methylation in association with early life stress as well as genome-wide association with MDD. Transl Psychiatry 2014; 4: e429.
Akula N, Barb J, Jiang X, Wendland JR, Choi KH, Sen SK et al. RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms and GTPase binding in bipolar disorder. Mol Psychiatry 2014; 19: 1179–1185.
Li K, Zhou T, Liao L, Yang Z, Wong C, Henn F et al. βCaMKII in lateral habenula mediates core symptoms of depression. Science 2013; 341: 1016–1020.
Novak G, Seeman P, Tallerico T . Increased expression of calcium/calmodulin-dependent protein kinase IIbeta in frontal cortex in schizophrenia and depression. Synap N Y N 2006; 59: 61–68.
Kang HJ, Voleti B, Hajszan T, Rajkowska G, Stockmeier CA, Licznerski P et al. Decreased expression of synapse-related genes and loss of synapses in major depressive disorder. Nat Med 2012; 18: 1413–1417.
Telegdy G, Adamik A . Anxiolytic action of neuromedin-U and neurotransmitters involved in mice. Regul Pept 2013; 186: 137–140.